NO991581L - N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler - Google Patents

N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler

Info

Publication number
NO991581L
NO991581L NO991581A NO991581A NO991581L NO 991581 L NO991581 L NO 991581L NO 991581 A NO991581 A NO 991581A NO 991581 A NO991581 A NO 991581A NO 991581 L NO991581 L NO 991581L
Authority
NO
Norway
Prior art keywords
benzothiazol
piperidine
preparation
therapeutic agents
ethanamine derivatives
Prior art date
Application number
NO991581A
Other languages
English (en)
Other versions
NO991581D0 (no
Inventor
Gihad Dargazanli
Pascal George
Patrick Lardenois
Jonathan Frost
Johannes Schoemaker
Maria-Carmen Renones
Pascale Magat
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO991581D0 publication Critical patent/NO991581D0/no
Publication of NO991581L publication Critical patent/NO991581L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Forbindelser med den generelle formel (I). hvor n representerer tallet 0, 1, 2 eller 3, Rx representerer et hydrogen- eller halogenatom eller en metyl- eller metoksy-gruppe, Rrepresenterer et hydrogenatom eller en metylgruppe og Rrepresenterer et hydrogenatom eller et eller to. halogenatomer. Forbindelsene er anvendbare i terapi.
NO991581A 1996-10-01 1999-03-30 N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler NO991581L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9611925A FR2753970B1 (fr) 1996-10-01 1996-10-01 Derives de n-(benzothiazol-2-yl) piperidine-1-ethanamine, leur preparation et leur application en therapeutique
PCT/FR1997/001692 WO1998014444A1 (fr) 1996-10-01 1997-09-26 Derives de n-(benzothiazol-2-yl)piperidine-1-ethanamine, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
NO991581D0 NO991581D0 (no) 1999-03-30
NO991581L true NO991581L (no) 1999-06-01

Family

ID=9496217

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991581A NO991581L (no) 1996-10-01 1999-03-30 N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler

Country Status (23)

Country Link
EP (1) EP0929550A1 (no)
JP (1) JP2001501217A (no)
KR (1) KR20000048767A (no)
CN (1) CN1230959A (no)
AR (1) AR009105A1 (no)
AU (1) AU722147B2 (no)
BG (1) BG103271A (no)
BR (1) BR9711842A (no)
CA (1) CA2266510A1 (no)
CO (1) CO4650030A1 (no)
CZ (1) CZ112699A3 (no)
EE (1) EE9900135A (no)
FR (1) FR2753970B1 (no)
HU (1) HUP9904091A3 (no)
IL (1) IL128902A (no)
NO (1) NO991581L (no)
NZ (1) NZ334553A (no)
PL (1) PL332648A1 (no)
SK (1) SK42299A3 (no)
TR (1) TR199900634T2 (no)
TW (1) TW438800B (no)
WO (1) WO1998014444A1 (no)
ZA (1) ZA978772B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9725541D0 (en) * 1997-12-02 1998-02-04 Pharmacia & Upjohn Spa Amino-benzothiazole derivatives
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
EP1303272B1 (en) 2000-06-21 2008-02-13 F. Hoffmann-La Roche Ag Benzothiazole derivatives for the treatment of alzheimer's disease and parkinson's disease
US7087761B2 (en) 2003-01-07 2006-08-08 Hoffmann-La Roche Inc. Cyclization process for substituted benzothiazole derivatives
BRPI0415767A (pt) * 2003-10-24 2006-12-26 Hoffmann La Roche antagonistas de receptor de ccr-3
AU2005247567B2 (en) 2004-05-24 2010-09-02 F. Hoffmann-La Roche Ag 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide
US7459563B2 (en) 2004-11-05 2008-12-02 Hoffmann-La Roche Inc. Process for the preparation of isonicotinic acid derivatives
BRPI0609719B8 (pt) 2005-03-23 2021-05-25 Hoffmann La Roche derivados de acetilenil-pirazol-pirimidina como antagonistas de mgbur2
BRPI0616571A2 (pt) 2005-09-27 2011-06-21 Hoffmann La Roche oxadiazolil pirazol-piridiminas como antagonistas de mglur2, processo para sua preparação, composição farmacêutica que os contém e uso dos mesmo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법

Also Published As

Publication number Publication date
AR009105A1 (es) 2000-03-08
FR2753970B1 (fr) 1998-10-30
NZ334553A (en) 2000-11-24
WO1998014444A1 (fr) 1998-04-09
AU722147B2 (en) 2000-07-20
EE9900135A (et) 1999-12-15
TW438800B (en) 2001-06-07
EP0929550A1 (fr) 1999-07-21
AU4463897A (en) 1998-04-24
JP2001501217A (ja) 2001-01-30
TR199900634T2 (xx) 1999-06-21
HUP9904091A2 (hu) 2000-05-28
CO4650030A1 (es) 1998-09-03
IL128902A0 (en) 2000-02-17
HUP9904091A3 (en) 2000-07-28
CN1230959A (zh) 1999-10-06
CA2266510A1 (en) 1998-04-09
ZA978772B (en) 1998-03-27
BR9711842A (pt) 1999-08-24
CZ112699A3 (cs) 1999-06-16
PL332648A1 (en) 1999-09-27
FR2753970A1 (fr) 1998-04-03
KR20000048767A (ko) 2000-07-25
SK42299A3 (en) 1999-12-10
IL128902A (en) 2001-07-24
NO991581D0 (no) 1999-03-30
BG103271A (en) 2000-05-31

Similar Documents

Publication Publication Date Title
NO20075065L (no) Anvendelse av isoflavonforbindelser til a behandle hjertesykdom
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
DK0977741T3 (da) Substituerede phenylderivater, deres fremstilling og anvendelse
MY119150A (en) Azetidine derivatives, their preparation and medicaments containing them
HUP0001192A2 (hu) Topiramát és származékainak alkalmazása elhízás kezelésére használható gyógyszerkészítmények előállítására
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
IL145602A0 (en) Pharmaceutical compounds
HUP0400837A2 (hu) 2-feniltiazol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
TR200000059T2 (tr) Piridin türevleri
DE60121461D1 (de) Kondensierte pyridoindolderivate
NO955326L (no) Isokinolinderivater, fremgangsmåte for deres fremstilling og terapeutiske anvendelse
DK0435749T3 (da) 2-Aminopyrimidin-4-carboxamid-derivater, deres fremstilling og deres terapeutiske anvendelse
NO991581L (no) N-(benzotiazol-2-yl)piperidin-1-etanaminderivater, deres fremstilling og anvendelse i terapeutiske midler
FR2631625B1 (fr) Derives de phenyl-6 piperazinylalkyl-3 1h,3h-pyrimidinedione-2,4, leur preparation et leur application en therapeutique
BR9913183A (pt) Composto, uso do mesmo, processo para prepará-lo, processo para tratar um indivìduo humano ou animal, e, composição farmacêutica
NO172846C (no) Fremgangsmaate for fremstilling av 7,8-dihalogen-3-metyl-2,3-dihydro-2m-benzoksazinderivater og propoksybenzenderivater for utoevelse av fremgangsmaaten.
NO970573D0 (no) Ylidenforbindelser og deres fremstilling
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
SE9603285D0 (sv) New compounds
SE9404525D0 (sv) New uses of indolo-(3,2-b)-quinoxalines
DK0607129T3 (da) Methylpiperazinoazepinderivater, deres fremstilling og deres anvendelse
DK497888D0 (da) N-(substitueret alkyliden)-1,2,3,4-tetrahydro-9-a cridinaminer, deres fremstilling og anvendelse
CA2142516A1 (en) Stilbene-Based Materials, Their Preparation and Use
NO890158D0 (no) Fremgangsmaate for fremstilling av hydroksialkyleringsmiddel, de oppnaadde midler og deres anvendelse.
SE8603589L (sv) Metylendioxifenantren- och stilbenderivat

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application